EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genistein Implications in Radiotherapy: Kill Two Birds with One Stone

Xiongxiong Liu iD, Tong Zheng, Yanyu Bao, Ping Li, Ting Zhao, Yan Liu iD, Hui Wang, Chao Sun iD

Molecules · 2025

DOI: 10.3390/molecules30010188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Xiongxiong Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Genistein, Neoplasms, Radiation-Sensitizing Agents, Radiation-Protective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Hundred People Program" of Chinese Academy of Sciences, the Natural Science Foundation of Gansu Province, the Longyuan Youth Talent Program of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 70% of cancer patients receive radiotherapy during their treatment, with consequent various side effects on normal cells due to high ionizing radiation doses despite tumor shrinkage. To date, many radioprotectors and radiosensitizers have been investigated in preclinical studies, but their use has been hampered by the high toxicity to normal cells or poor tumor radiosensitization effects. Genistein is a naturally occurring isoflavone found in soy products. It selectively sensitizes tumor cells to radiation while protecting normal cells from radiation-induced damage, thus improving the efficacy of radiotherapy and consequent therapeutic outcomes while reducing adverse effects. Genistein protects normal cells by its potent antioxidant effect that reduces oxidative stress and mitigates radiation-induced apoptosis and inflammation. Conversely, genistein increases the radiosensitivity of tumor cells through specific mechanisms such as the inhibition of DNA repair, the arrest of the cell cycle in the G2/M phase, the generation of reactive oxygen species (ROS), and the modulation of apoptosis. These effects increase the cytotoxicity of radiation. Preclinical studies demonstrated genistein efficacy in various cancer models, such as breast, prostate, and lung cancer. Despite limited clinical studies, the existing evidence supports the potential of genistein in improving the therapeutic effect of radiotherapy. Future research should focus on dosage optimization and administration, the exploration of combination therapies, and long-term clinical trials to establish genistein benefits in clinical settings. Hence, the unique ability of genistein to improve the radiosensitivity of tumor cells while protecting normal cells could be a promising strategy to improve the efficacy and safety of radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenisteinNeoplasmsRadiation-Sensitizing AgentsRadiation-Protective AgentsHumansAnimalsApoptosisRadiation ToleranceReactive Oxygen SpeciesOxidative Stress

Stichwörter der Autor:innen

cancer treatmentgenisteinradioprotectionradiosensitizationradiotherapy

Substanzen

GenisteinRadiation-Sensitizing AgentsReactive Oxygen SpeciesRadiation-Protective Agents

Autor:innen und Institutionen

  • Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
  • Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, China.
  • Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Lanzhou 730000, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • School of Medical Imaging, Binzhou Medical University, Yantai 264003, China.

ORCID-Profile: Xiongxiong Liu, Yan Liu, Chao Sun

Förderung

  • "Hundred People Program" of Chinese Academy of Sciences
  • the Natural Science Foundation of Gansu Province
  • the Longyuan Youth Talent Program of Gansu Province
  • “Hundred People Program” of the Chinese Academy of Sciences

Zitieren

APA

Liu, X., Zheng, T., Bao, Y., Li, P., Zhao, T., Liu, Y., Wang, H., & Sun, C. (2025). Genistein Implications in Radiotherapy: Kill Two Birds with One Stone. Molecules. https://doi.org/10.3390/molecules30010188

Vancouver

Liu X, Zheng T, Bao Y, Li P, Zhao T, Liu Y, et al. Genistein Implications in Radiotherapy: Kill Two Birds with One Stone. Molecules. 2025. doi:10.3390/molecules30010188

BibTeX
@article{Liu2025,
  author = {Liu, Xiongxiong and Zheng, Tong and Bao, Yanyu and Li, Ping and Zhao, Ting and Liu, Yan and Wang, Hui and Sun, Chao},
  title = {Genistein Implications in Radiotherapy: Kill Two Birds with One Stone},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30010188}
}
Kostenlos starten →